ACT-HBV® : Advancing the Clinical Treatment of Hepatitis B Virus
Home CME Center Clinical Trials About ACT-HBV® Treatment Algorithms and Guidelines Ask the Experts
CME Center
 
Select a Category:

  
 
Chronic Hepatitis B
A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of 12 Weeks, Oral Treatment With ACH126, 433 (b-L-Fd4C) in Adults with Lamivudine-Resistant Chronic Hepatitis B
   
A Phase IIIb Comparative Trial of Entecavir versus Adefovir in the Treatment of Chronic Hepatitis B Infection
   
A Single Center Open-Label, Randomized Study Comparing the Safety of Immediately Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir for 12 Weeks Before Instituting Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B
   
A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection
   
A Study in Korea of the Antiviral Activity and Safety of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection Who Are Negative For Hepatitis B e Antigen
   
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
   
A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B
   
A Study of PEGASYS® (Peginterferon Alfa-2a [40KD]) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB)
   
A Study to Compare Tenofovir versus Hepsera (Adefovir) for the Treatment of HBeAg Negative Chronic Hepatitis B
   
A Study to Compare the Effectiveness and Safety of Telbivudine Used in Combination With Peginterferon Against Peginterferon Used Alone and Against Telbivudine Used Alone
   
ACH126, 433 in Lamivudine-Resistant Chronic Hep B
   
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B (CHB) Patients
   
Adefovir Dipivoxil for the Treatment of Patients With Chronic Hepatitis B–Related Advanced Fibrosis or Cirrhosis
   
Adefovir Dipivoxil in Compensated Chronic Hepatitis B Patients
   
Adefovir Dipivoxil Tablets (10 mg) in Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
   
An Early Access Program for Entecavir in Patients with Chronic Hepatitis B
   
An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
   
Antibody Response and Immune Memory 15-18 Years After HBV Vaccination
   
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
   
Apoptosis and Hepatitis B: The Role of Apoptosis in Patients Who Are HBeAg Negative
   
Cellular Immune Responses to Hepatitis B Virus (HBV)–- Longitudinal Follow Up and Natural History
   
Compare the Efficacy and Safety of 48-Week Treatment With Clevudine 30mg versus Lamivudine 100mg for CHB Infection
   
Comparison of Entecavir to Adefovir in Chronic HBV Patients with Hepatic Decompensation
   
Comparison of the Safety and Efficacy of Telbivudine versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
   
Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?
   
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
   
Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellulary Carcinoma
   
Effectiveness of Lamivudine in Patients with Chronic Hepatitis B
   
Effectiveness of Two Hepatitis B Vaccines in HIV-Negative Youths
   
Efficacy and Safety of Telbivudine in Treatment Naïve Patients With HBeAg-Positive Chronic Hepatitis B (CHB)
   
Efficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients
   
Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients
   
Efficacy Study of Thymosin alpha1 and Pegylated Interferon-alpha-2a to Treat Chronic Hepatitis B
   
Entecavir for Subjects With Chronic Hepatitis B Infection :An Early Access Program
   
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy and Adefovir Monotherapy for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus
   
Entecavir Plus Adefovir Versus Entecavir or Adefovir Monotherapy for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus
   
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
   
Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha-2a
   
Evaluation of Chronic HBV Patients with Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases
   
Evaluation of the Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents with Chronic Hepatitis B
   
FibroScan in Patients with Hepatitis B and C Presenting for Liver Biopsy
   
Hepatitis B Vaccination of Youth at Adolescent Trial Network Sites: Effectiveness of Two Strategies and Evaluation of Tools to Be Used in Future HIV Prevention Trial
   
Hepatitis B Vaccine Booster Study
   
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT
   
Identification of Biomarkers Associated with Human Hepatocellular Carcinoma by SELDI
   
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3, and 4 months of Age
   
Lamivudine and Adefovir to Treat Chronic Hepatitis B
   
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)
   
Long Term Follow-Up of Pegylated-Interferon Alpha-2b
   
Long-Term Lamivudine Therapy for Chronic Hepatitis B
   
Optimizing Hepattis B Vaccine Response Through the Use of a Topical Immune Modulator
   
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
   
Peg-Intron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (Study P04498)
   
Pegylated Alfa Interferon in Patients with Chronic Hepatitis B and Chronic Hepatitis D
   
Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
   
Persistence of Hepatitis B Antibody Levels and Immune Response to a Hepatitis B Vaccine Challenge
   
Phase II Study of the Safety and Efficacy of Lamivudine plus Adefovir Versus Adefovir Alone to Treat Patients with Chronic Hepatitis B Infection
   
Phase III Study on Efficacy, Safety, and Pharmacokinetics of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B and Varying Degrees of Renal Impairment
   
Prevention of Recurrent Hepatitis B after Liver Transplantation
   
Prospective Cohort Study of the Effect of Serum HBV DNA Level on Intrahepatic Recurrence in Local HCC Related With HBV
   
Randomized, Double Blind Trial of Telbivudine versus Lamivudine in Adults with Compensated Chronic Hepatitis B
   
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection
   
SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB)
   
Studies of Immune Responses in Patients with Chronic Hepatitis B
   
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.
   
Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B
   
Study of Combination Therapy With LdT plus Adefovir versus Adefovir Alone
   
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection
   
Study to Compare the Effectiveness and Safety of Telbivudine Used in Combination with Peginterferon Against Peginterferon Used Alone and Against Telbivudine Used Alone
   
Summary: A Randomized, Double-Blind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil for the Treatment of Presumed Pre-core Mutant Chronic Hepatitis [GS-US-174-0102]
   
Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B
   
Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies
   
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
   
Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B
   
test
   
To Assess the Immune Response Following Primary Vaccination withTwo Formulations of DTPw-HBV/Hib Vaccine When Given with Rotavirus Vaccine to Infants at 3, 4 1/2, and 6 Months of Age
   
Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil
   
Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients Who Have Failed Antiviral Treatment
   
Trial of Telbivudine Versus Placebo as Adjunct Therapy to Adefovir
   
VaxTeen Hepatitis B Vacccine Booster Study
   
Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B
   
HBV/HIV Coinfection
4-Methylumbelliferone as a Treatment for Chronic HBV/HCV
   
A Phase II Study of Entecavir Plus Lamivudine in Hepatitis B/HIV Coinfected Patients
   
A Phase II Study of the Safety and Efficacy of Adefovir and Tenofovir in Patients Infected with Lamivudine-Resistant Hepatitis B and HIV
   
A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth
   
Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
   
Comparison of the Safety and Immune Response to an HBV Vaccine Given with a Booster (CpG7909 ODN) in HIV-infected and HIV-Unifected Individuals with Hepatitis B and In Healthy Volunteers
   
Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth
   
Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients
   
Efficacy of Tenofovir and Emtricitabine in ARV-Naïve Patients with HIV/HBV Co-Infection
   
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
   
Evaluation of the Safety and Effectiveness of Adefovir Plus Lamivudine for Chronic Hepatitis B Infection in Patients With and Without HIV Infection
   
Evaluation of the Safety and Effectiveness of the Combination of Adefovir Dipivoxil and Lamivudine in Hepatitis B/HIV-Coinfected Patients with Liver Cirrhosis
   
Hepatitis B Vaccination in HIV-Infected Persons
   
Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs
   
Immunologic Memory (Sup. Of ATN 024)
   
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Coinfection and Chronic Hepatitis C
   
Project UNITY - HIV Risk Reduction and Vaccine Education Interventions
   
Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
   
Tenofovir in HIV/HBV Coinfection
   
Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV Coinfection
   
  
 
Online ResourcesContact Us Refer a Colleague Send Me Updates Legal Disclaimer
  
   
 
MDGUniversity of Wisconsin Medical School
The ACT-HBV Initiative in the United States is supported by independent educational grants from Bristol-Myers Squibb Company and Gilead Sciences. The ACT-HBV Initiative in the Asia-Pacific Region is supported by independent educational grants from Bristol-Myers Squibb Company and Novartis Pharma AG.